NAME A/Prof. Peter Janes
CANCER TYPE General
INSTITUTION Olivia Newton-John Cancer Research Institute
GRANT TYPE $50,000
PROJECT TYPE Research
Targeting active ADAM10 in tumours
"We now wish to test if our novel antibody can be used to selectively kill tumour cells, using anti-ADAM10 ADCs. We will test different types of anti-ADAM ADCs on tumour cells in culture and in mice, to determine their effectiveness and safety. We will also test the potential for these drugs to improve treatment of drug resistant tumours."
-A/Prof. Peter Janes, Olivia Newton-John Cancer Research Institute